Diabetes News

Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the body's ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes.

Researchers have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.

A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers.

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease.

Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.

American women have gotten fatter as it has become more socially acceptable to carry a few extra pounds, according to a new study.

Mothers of babies born with some structural birth defects, including missing limbs, malformed hearts and underdeveloped spinal cords, appear more likely to be obese prior to becoming pregnant than mothers whose children are born without such defects.

A new drug is showing great promise in returning patients with type 1 diabetes to insulin independence.

A study from Children's Hospital Boston finds that reducing insulin levels in the brain boosts longevity. Though it was done in genetically engineered mice, old-fashioned exercise and good diets also keep brain insulin levels low in humans.

Individuals with diabetes appear to spend more days in the intensive care unit, use more ventilator support and have more complications during hospitalization for trauma than non-diabetics, according to a July 2007 report.

Using innovative high-density DNA microchip technology, which can test 550,000 genes in a single analysis, researchers have detected a new gene involved in type 1 diabetes.

New studies are needed to assess the trade-offs between potential benefits and potential harms when rosiglitazone is used by people with type 2 diabetes.

There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1.

Orange juice, despite its high caloric load of sugars, appears to be a healthy food for diabetics due to its mother lode of flavonoids, a study by endocrinologists at the University at Buffalo has shown.

Selenium, an antioxidant included in multivitamin tablets thought to have a possible protective effect against the development of type 2 diabetes, may actually increase the risk of developing the disease.

There are no high quality data to assess how well dietary treatments for type 2 diabetes work in people who have just been told they have the disease, but there is evidence that taking on exercise seems to be one way of improving blood sugar levels.